Cargando…
P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430874/ http://dx.doi.org/10.1097/01.HS9.0000849300.97009.0e |
_version_ | 1784779897182355456 |
---|---|
author | Dimou, M. Speletas, M. Milito, C. Huscher, D. Kamieniak, M. Pittrow, D. Borte, M. |
author_facet | Dimou, M. Speletas, M. Milito, C. Huscher, D. Kamieniak, M. Pittrow, D. Borte, M. |
author_sort | Dimou, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9430874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94308742022-08-31 P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY Dimou, M. Speletas, M. Milito, C. Huscher, D. Kamieniak, M. Pittrow, D. Borte, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430874/ http://dx.doi.org/10.1097/01.HS9.0000849300.97009.0e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Dimou, M. Speletas, M. Milito, C. Huscher, D. Kamieniak, M. Pittrow, D. Borte, M. P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
title | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
title_full | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
title_fullStr | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
title_full_unstemmed | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
title_short | P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY |
title_sort | p1611: insights into facilitated immunoglobulin (fscig) use in patients with secondary immunodeficiency diseases: final results from the figaro study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430874/ http://dx.doi.org/10.1097/01.HS9.0000849300.97009.0e |
work_keys_str_mv | AT dimoum p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT speletasm p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT militoc p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT huscherd p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT kamieniakm p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT pittrowd p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy AT bortem p1611insightsintofacilitatedimmunoglobulinfsciguseinpatientswithsecondaryimmunodeficiencydiseasesfinalresultsfromthefigarostudy |